Less Red Ink: A Design Discipline for UK Medical-Legal Review Submissions

Few routines in UK medical communications are as predictable as the first-pass rejection. A pack leaves the agency with a tidy cover note and returns with a familiar trail of comments: a claim that outruns its evidence, a reference that lands on the wrong paragraph, an annotation that explains the obvious while missing the contested point, or two versions of the same slide circulating in different inboxes. It is tempting to treat these as ordinary hazards of medical-legal-regulatory (MLR) review. A more useful position is to treat them as design failures — predictable ones that can be reduced before the pack leaves the building.

Why first-pass failure is usually structural

MLR review is often described as a gatekeeping step, but in practice it is a reading exercise conducted under time pressure. The reviewer is asking a small number of hard questions: what exactly is being claimed, what supports it, is the support adequate and current, and is the wording consistent with the licensed indication and the relevant code? When the pack makes those questions difficult to answer, comments multiply. When it makes them easy, review becomes faster and more focused.

The implication is straightforward. A clean first pass is not primarily a matter of luck or reviewer temperament. It is the result of decisions made earlier: how claims were inventoried, how evidence was mapped, how annotations were written, how versions were controlled and how the final pack was triaged before submission. Account handlers, medical writers and reviewers all shape those decisions, which is why the discipline has to be shared rather than owned by one role.

Start with the claim, not the slide

A common weakness in UK MLR packs is that the artwork leads and the substantiation follows. The deck or leavepiece is built first, then references are attached to whatever wording survives. This sequence invites trouble. A more robust approach begins with a claim inventory: a plain list of every statement that asserts benefit, safety, prevalence, burden, mechanism, comparison or clinical action. Each entry should record the exact wording, its location in the material, the intended audience and the evidence that supports it.

The inventory does not need to be elaborate, but it should be explicit. For each claim, the team should be able to point to the source, the relevant page or section, the study population, the endpoint and the direction of effect. Where a claim depends on a subgroup, a post hoc analysis or a secondary endpoint, that dependency should be visible rather than buried in a reference list. Where the evidence is supportive but not definitive, the wording should reflect that distinction. Reviewers are rarely troubled by cautious language; they are troubled by ambiguity.

Reference trails that survive scrutiny

Reference trails fail in ordinary ways. A citation points to an abstract when the claim depends on the full paper. A page number is missing. A URL has moved. A secondary source is cited where the primary source is available. A statement about UK practice relies on a study conducted in a different health system without saying so. None of these is exotic, but each creates a reason to send the pack back.

The practical response is to treat the reference trail as part of the content, not as an appendix. Each source should be checked for currency, relevance and accessibility. Page or paragraph locations should be recorded at the point of annotation. Where a claim draws on multiple sources, the relationship between them should be clear: does one confirm the other, extend it, or qualify it? Where a source is behind a paywall, the team should consider whether the reviewer will have access and whether a summary or permission-cleared extract is needed. The aim is not to over-document every sentence, but to ensure that the contested sentences can be verified without a scavenger hunt.

Annotation as a reader service

Annotation discipline is often misunderstood. Annotations are not a place to repeat the slide in different words, nor are they a dumping ground for every reference the team has read. They are a navigation aid for a reviewer who needs to move quickly from claim to evidence. Good annotation is specific, proportionate and located close to the claim it supports.

A useful rule is one primary annotation per substantive claim, with additional notes only where the evidence needs qualification. The annotation should identify the source, the relevant location and the precise element that supports the wording. If the claim is comparative, the comparator should be named. If the claim concerns a UK licensed indication, the annotation should make that clear. If the evidence is observational, the annotation should not imply causal certainty. Reviewers notice these distinctions because they are the distinctions that matter to sign-off.

Version control without theatre

Many bounce-backs are version-control failures dressed as content queries. The reviewer receives a pack that does not match the reference document, or a slide that has been updated without a corresponding change to the annotation, or a file name that suggests finality when the document is still in draft. The remedy is unglamorous: a single source of truth, a clear naming convention, a change log for substantive edits and a rule that comments are resolved in the document rather than across email threads.

For UK teams working with affiliate clients and global colleagues, the risk multiplies. It helps to agree at the outset which document is authoritative, who can make changes, and how those changes will be communicated. A short cover note that lists the version, the date, the changes since the last review and any open issues can save a great deal of correspondence. It also gives the reviewer a reason to trust the pack's internal consistency.

The pre-submission triage hour

Before anything leaves the agency, a short triage meeting can catch many avoidable problems. The attendees should include the writer, the account handler and a reviewer who has not been immersed in the document. The agenda should be narrow: claims without visible support, references that cannot be verified quickly, annotations that do not match the claim, version inconsistencies and any wording that depends on an assumption the client has not confirmed.

The triage is not a rehearing of the medical and regulatory debate. It is a check that the pack is readable as a submission. The team should leave with a short list of fixes, an owner for each and a decision on whether the pack is ready to go. Giving the triage group the authority to stop a submission is useful, but only if the stop is followed by a rapid fix rather than a postponement without a plan.

What to measure afterwards

A design discipline improves only if the team learns from what comes back. A simple log of first-pass comments, grouped by cause, can reveal patterns: repeated reference-format issues, recurring claim-wording problems, annotation gaps in a particular therapeutic area or version-control failures with a particular client. Over time, those patterns should feed back into templates, checklists and training.

The goal is not a perfect record or a frictionless review. MLR review exists to test the material, and some comments will always be substantive. The goal is to remove the comments that were predictable before the pack was submitted. Less red ink on the first pass is not a cosmetic victory; it is evidence that the team has designed the submission around the reviewer's questions rather than around the agency's convenience.